SCHEMBL6134458

SCHEMBL6134458

CC(C)n1nc(-c2sc(NC(=O)c3cccc(C(F)(F)F)c3)nc2-c2ccccc2)ccc1=O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 6/20 0.48
ADORA1 P30542 4/20 0.48
MAPT P10636 3/20 0.46
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
MAPK14 Q16539 1/20 0.43
ALDH1A1 P00352 2/20 0.43
RXFP1 Q9HBX9 1/20 0.42
LMNA P02545 2/20 0.42
ADCY1 Q08828 1/20 0.42
ADORA3 P0DMS8 3/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPK1 P28482 1/20 0.41
KCNK3 O14649 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133305 0.93 ADORA2A (0.47) ADORA2AADORA1MAPTKDM4EALDH1A1
SCHEMBL6133424 0.91 ADORA2A (0.51) ADORA2AADORA1MAPTKDM4EALDH1A1
SCHEMBL6133489 0.89 ADORA2A (0.50) ADORA2AADORA1MAPTKDM4EALDH1A1
SCHEMBL6133303 0.89 ADORA2A (0.60) ADORA2AADORA1MAPTALDH1A1ADORA3
SCHEMBL6133216 0.88 ADORA2A (0.51) ADORA2AADORA1MAPTKDM4EPOLB
SCHEMBL6133367 0.87 ADORA1 (0.50) ADORA2AADORA1MAPTKDM4EPOLB
SCHEMBL6133287 0.85 ADORA1 (0.49) ADORA2AADORA1MAPTALDH1A1ADORA3
SCHEMBL6133257 0.84 SMN1; SMN2 (0.56) ADORA2AADORA1MAPTKDM4EALDH1A1
SCHEMBL6133159 0.84 ADORA2A (0.53) ADORA2AADORA1MAPTKDM4EMAPK14
SCHEMBL6133853 0.84 ADORA2A (0.43) ADORA2AADORA1MAPTALDH1A1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR ADORA2A 635/4885ADORA1 243/4885MAPT 3008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.